News-medical: October 26, 2012 A new Lancet Series explores the latest developments in the diagnosis, treatment and biology of cardiac arrhythmias, ahead of the American Heart Association’s annual meeting taking place this year on Nov 3–7 in Los Angeles, CA, USA. Arrhythmias – problems with the heartbeat’s rate or rhythm, where the heart beats too quickly, too slowly, […]
Journal o f Arrhythmia: 10/18/12 The development and introduction of radiofrequency ablation devices allowed maze procedure to be performed safely and easily, further enabling off-pump pulmonary vein isolation through mini-thoracotomy or thoracoscopy. The outcomes of the maze procedure include the prevention of stroke and other complications related to atrial fibrillation (AF), improvement in cardiac performance, and […]
Association of Body Mass Index, Diabetes, Hypertension, and Blood Pressure Levels with Risk of Permanent Atrial Fibrillation Read More
Diabetes Care: 7/26/12 To examine whether baseline pulse pressure (PP), a marker of arterial stiffness, is associated with subsequent development of atrial fibrillation (AF) in type 2 diabetes. RESEARCH DESIGN AND METHODS A total of 350 type 2 diabetic patients, who were free from AF at baseline, were followed for 10 years. A standard electrocardiogram was performed […]
The American Journal of Medicine: November 1, 2012 Atrial fibrillation is common among patients with cardiovascular disease and is a frequent complication of the acute coronary syndrome. Data are needed on recent trends in the magnitude, clinical features, treatment, and prognostic impact of preexisting and new-onset atrial fibrillation in patients hospitalized with an acute coronary […]
Stop AFIB: October 24, 2012 Brussels, Belgium — October 24, 2012 — Ahead of World Stroke Day 2012 (October 29), European Policy Makers have joined over 90 Medical and Patient Organisations, and more than 100,000 people, in supporting the Global Atrial Fibrillation (AF) Patient Charter and calling for National Governments and the World Health Organisation to act to make the […]
JAMA Network: October 22, 2012 The major challenges of warfarin therapy relate to poor adherence and persistence, the need for regular monitoring, and the risk of hemorrhage. In clinical trials, persistence with warfarin treatment ranges from 75% to 79% at 1 year,1– 2 but persistence in clinical practice is thought to be poorer. Small observational studies suggest […]
Journal of Cardiovascular Disease Research: October 19, 2012 Atrial fibrillation (AF) is recognized as the most common cardiac arrhythmia, accounting for a lifetime risk of about 25%. [1],[2],[3] It presents a 5-6 fold increased stroke risk and accounts for at least one in every seven ischemic strokes. The common conception is that highest risk of embolic stroke is […]
Biomedcentral: 10/18/12 There is limited information about any association between the onset of atrial fibrillation (AF) and the presence of valvular disease. Methods We retrospectively examined 940 patients in sinus rhythm, examined by echocardiography in 1996. During 11 years of follow-up, we assessed the incidence of AF and outcome defined as valvular surgery or death, in […]
Plosone: 10/15/12 Precise mechanisms of atrial fibrillation (AF) are uncertain, but their association with esophageal disorders has been recently proposed. The association between gastroesophageal reflux disease (GERD), the most common gastroesophageal disorder, and AF remains undetermined. We therefore aimed to investigate the association between GERD and later development of AF. Read More
